Difference between revisions of "Team:Freiburg/Collaborations"
| Line 139: | Line 139: | ||
<h1> ETH Zurich 2016 iGEM team </h1> | <h1> ETH Zurich 2016 iGEM team </h1> | ||
| − | + | The team from Zurich is also focussing on Colitis ulcerosa so a collaboration seemed reasonable. They helped us by modelling the needed parameter estimation for the kill-switch of Bacillus subtilis for our project. | |
| + | Check out their project<a href="https://2016.igem.org/Team:ETH_Zurich " id="badge2" target="_blank">here.</a> | ||
| + | |||
| + | |||
</div> | </div> | ||
| Line 166: | Line 169: | ||
<h1> Bielefeld CeBiTec 2016 iGEM team </h1> | <h1> Bielefeld CeBiTec 2016 iGEM team </h1> | ||
| − | + | <div> For the establishment of a specific binding of our anti-GFP nanobody we followed different approaches(hier könnten wir einen link zum adhesion results machen). Another idea to test this binding was provided by this year’s iGEM team of Bielefeld, which are also working with nanobodies. They send us a GFP-split-CFP on pSB1C3 vector and anti-GFP nanobody-split-CFP on pSB1K3 vector to verify the binding of our nanobody. | |
| + | Unfortunately, we were not able to test with the split proteins we received from team Bielefeld due to time constraints. | ||
| + | |||
| + | Check out their project<a target="_blank" href='https://2016.igem.org/Team:Bielefeld-CeBiTec' style="text-align: center;font-size:20px;color:#e8a126">here.</a> | ||
| + | |||
| + | </div> | ||
</div> | </div> | ||
Revision as of 01:06, 16 October 2016
Collaborations
"Unity is strength. . . when there is teamwork and collaboration, wonderful things can be achieved." -Mattie Stepanek
XMU-China 2016 iGEM team
The iGEM team of the Xiamen University came up with the fantastic idea to unite iGEMers all over the world and founded an information exchange platform named Newsletter. This year 46 teams from 21 countries and regions joined them! This issue consists of the following five main elements: introduction, human practice, collaboration, discussion and survey and of course we took our part in it and contributed our project to raise awareness of Ulcerative colitis. Read this interesting Newsletter here (our part starts on page 40! ) Check out their project here
Technion Israel 2016 iGEM team
TEXT
UBonn HBRS 2016 iGEM team
TEXT
Virginia 2016 iGEM team
This year’s iGEM team of Virginia conducted a survey about biocontainment in which we gladly participated. We learnt a lot about this important topic and are happy we could help. Check out their project here.Evry 2016 iGEM team
Thanks to the Evry team we were educated in the field of polylactic acid (PLA) as an interesting molecule for biodegradable plastic. By partaking their survey we supported their idea. Check out their project here.Tel- Hai Israel 2016 iGEM team
TEXT
ETH Zurich 2016 iGEM team
The team from Zurich is also focussing on Colitis ulcerosa so a collaboration seemed reasonable. They helped us by modelling the needed parameter estimation for the kill-switch of Bacillus subtilis for our project. Check out their projecthere.Pasteur Paris 2016 iGEM team
Who says that collaborations always have to be scientific? In a more fun and unconventional way we exchanged a care-package with regional specialities with this year’s Pasteur Paris team. We didn’t mentioned this collaboration till a mysterious package arrived. This amazing surprise charged everyone's batteries and brought twinkles in our team’s eyes.
Check out their project here.
Bielefeld CeBiTec 2016 iGEM team
For the establishment of a specific binding of our anti-GFP nanobody we followed different approaches(hier könnten wir einen link zum adhesion results machen). Another idea to test this binding was provided by this year’s iGEM team of Bielefeld, which are also working with nanobodies. They send us a GFP-split-CFP on pSB1C3 vector and anti-GFP nanobody-split-CFP on pSB1K3 vector to verify the binding of our nanobody.
Unfortunately, we were not able to test with the split proteins we received from team Bielefeld due to time constraints.
Check out their projecthere.
